Skip to main content
G

GekkoVet

GekkoVet offers a veterinary diagnostic platform that utilizes scientifically validated algorithms to generate probable diagnoses and treatment options for dogs and cats in seconds. This tool addresses the need for rapid and accurate clinical decision support, enabling veterinarians to enhance patient care efficiently.

Helsinki, FinlandFounded 2018121K+ followers
Updated 20 months ago

Funding

$200K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

LV
Funding rounds are not available yet.

Founders

Product

Problem

Veterinarians often need rapid and accurate diagnostic support to efficiently assess patient conditions, especially when dealing with a wide range of potential ailments in dogs and cats. Traditional diagnostic processes can be time-consuming, potentially delaying treatment decisions.

Solution

GekkoVet offers a veterinary diagnostic platform that provides quick diagnostic and treatment assistance for dogs and cats. The platform utilizes scientifically validated algorithms and a knowledge base curated by veterinarians to generate probable diagnoses and treatment options within seconds. By simply inputting symptoms, veterinarians can leverage GekkoVet to receive information about potential diseases and treatment options, enhancing the speed and accuracy of clinical decision-making.

Target Audience

The primary users are veterinarians and veterinary students seeking a tool for rapid and accurate clinical decision support for canine and feline patients.

Features

  • AI-powered diagnostic platform using scientifically validated knowledge.
  • Probable diagnoses and treatment options generated in seconds.
  • Professionally curated knowledge base by a team of veterinarians.
  • Supports a range of symptoms, including Polyuria/Polydipsia (PU/PD, PUPD) and Abdominal distention.
  • Diagnostic support for conditions like Hyperadrenocorticism (Cushing's Disease) and Thyroid Neoplasia.
  • Provides treatment options, such as the use of Trilostane for Hyperadrenocorticism.
This profile is AI-generated and may contain inaccuracies.